Search
for
Sort by
Research 61–90 of 279
- Hypersensitivity Reactions to Anticoagulant Drugs
- Ethinylestradiol/Chlormadinone Acetate
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Exosomes in Skin of Color: Dermatological Insights, Therapeutic Potential, and Clinical Realities in India
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Enhancing dermatology clinical trials: optimizing sites and strategies for success in India
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Ritlecitinib in severe alopecia areata: a profile of its use
- Herbal Nanocosmeceuticals: The Ultimate Fusion of Science and Nature
- Anticonvulsant-Induced Cutaneous Reactions
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Poster Abstracts
- Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians
- Clinical experience with Valette®
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Risks of Skin, Hair, and Nail Supplements
- Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database